ArticleTranslational lung cancer research2025
Comparison of efficacy and surgery-related safety of perioperative tislelizumab and pembrolizumab with neoadjuvant chemotherapy for resectable non-small cell lung cancer: a retrospective cohort study.
Yizhang Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.